Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Accenture
QuintilesIMS
Cipla
Federal Trade Commission
US Department of Justice
Dow
Mallinckrodt
Queensland Health
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

Mupirocin calcium - Generic Drug Details

« Back to Dashboard

What are the generic sources for mupirocin calcium and what is the scope of mupirocin calcium patent protection?

Mupirocin calcium
is the generic ingredient in two branded drugs marketed by Glaxosmithkline and Glenmark Pharms Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for mupirocin calcium. Eight suppliers are listed for this compound.
Pharmacology for mupirocin calcium

US Patents and Regulatory Information for mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Pharms Inc MUPIROCIN mupirocin calcium CREAM;TOPICAL 201587-001 Jan 24, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for mupirocin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 ➤ Subscribe ➤ Subscribe
Glaxosmithkline BACTROBAN mupirocin calcium CREAM;TOPICAL 050746-001 Dec 11, 1997 ➤ Subscribe ➤ Subscribe
Glaxosmithkline BACTROBAN mupirocin calcium OINTMENT;NASAL 050703-001 Sep 18, 1995 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cipla
Mallinckrodt
Baxter
Argus Health
Moodys
UBS
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot